Demegen develops novel and natural peptides for the treatment of bacterial and fungal infections. Demegen operates primarily with strategic partners and development efforts are underway for a number of dermatological, ophthalmic, cosmetic and agricultural applications. Other products to be developed include a treatment for cystic fibrosis infections.
View Top Employees from Demegen| Website | http://www.demegen.com |
| Revenue | $17 million |
| Employees | View employees |
| Founded | 1992 |
| Address | 1051 Brinton Rd, Pittsburgh, Pennsylvania 15221, US |
| Phone | (412) 241-2150 |
| Fax | (412) 241-2161 |
| Industry | Business Services General, Pharmaceutical, Biotechnology, Business Services, Health Care, Other Pharmaceuticals and Biotechnology |
| Competitors | Anokion, Galecto, Inc., Protagonist Therapeutics, Sequella, Inc., Xenon Pharmaceuticals Inc. |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies |
Looking for a particular Demegen employee's phone or email?
Demegen Questions
The Demegen annual revenue was $17 million in 2024.
Demegen is based in Pittsburgh, Pennsylvania.
The NAICS codes for Demegen are [54, 541, 54171, 5417, 541714].
The SIC codes for Demegen are [87, 873].
